EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors

Eunji Choi iD, Yue Hua iD, Chloe C Su iD, Julie T Wu, Joel W Neal iD, Ann N Leung, Leah M Backhus iD, Christopher Haiman iD, Loïc Le Marchand iD, Su-Ying Liang iD, Heather A Wakelee iD, Iona Cheng iD und 1 weitere

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Eunji Choi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Lung Neoplasms, Neoplasms, Second Primary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent therapeutic advances have improved survival among lung cancer (LC) patients, who are now at high risk of second primary lung cancer (SPLC). Hispanics comprise the largest minority in the United States, who have shown a lower LC incidence and mortality than other races, and yet their SPLC risk is poorly understood. We quantified the SPLC incidence patterns among Hispanics vs other races.

Methods

We used data from the Multiethnic Cohort, a population-based cohort of 5 races (African American, Japanese American, Hispanic, Native Hawaiian, and White), recruited between 1993 and 1996 and followed through 2017. We identified patients diagnosed with initial primary lung cancer (IPLC) and SPLC via linkage to Surveillance, Epidemiology, and End Results registries. We estimated the 10-year cumulative incidence of IPLC (in the entire cohort) and SPLC (among IPLC patients). A standardized incidence ratio (SIR) was calculated as the ratio of SPLC-to-IPLC incidence by race and ethnicity.

Results

Among 202 692 participants, 6788 (3.3%) developed IPLC over 3 871 417 person-years. The 10-year cumulative IPLC incidence was lower among Hispanics (0.80%, 0.72 to 0.88) vs Whites (1.67%, 1.56 to 1.78) or Blacks (2.44%, 2.28 to 2.60). However, the 10-year SPLC incidence following IPLC was higher among Hispanics (3.11%, 1.62 to 4.61) vs Whites (2.80%, 1.94 to 3.66) or Blacks (2.29%, 1.48 to 3.10), resulting in a significantly higher SIR for Hispanics (SIR = 8.27, 5.05 to 12.78) vs Whites (SIR = 5.60, 4.11 to 7.45) or Blacks (SIR = 3.48, 2.42 to 4.84; P < .001).

Conclusion

Hispanics have a higher SPLC incidence following IPLC than other races, which may be potentially due to better survival after IPLC and extended duration for SPLC development. Continuing surveillance is warranted to reduce racial disparities among LC survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsLung NeoplasmsNeoplasms, Second PrimaryAgedFemaleHumansMaleMiddle AgedAsianBlack or African AmericanCohort StudiesHispanic or LatinoIncidenceNative Hawaiian or Pacific IslanderSEER ProgramUnited StatesWhite

Autor:innen und Institutionen

  • Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
  • Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Veterans Affairs, Veterans Affairs Palo Alto Health Care, Palo Alto, CA, USA.
  • Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.

ORCID-Profile: Eunji Choi, Yue Hua, Chloe C Su, Joel W Neal, Leah M Backhus, Christopher Haiman, Loïc Le Marchand, Su-Ying Liang, Heather A Wakelee, Iona Cheng, Summer S Han

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Choi, E., Hua, Y., Su, C. C., Wu, J. T., Neal, J. W., Leung, A. N., Backhus, L. M., Haiman, C., Le Marchand, L., Liang, S. Y., Wakelee, H. A., Cheng, I., & Han, S. S. (2024). Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae072

Vancouver

Choi E, Hua Y, Su CC, Wu JT, Neal JW, Leung AN, et al. Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae072

BibTeX
@article{Choi2024,
  author = {Choi, Eunji and Hua, Yue and Su, Chloe C and Wu, Julie T and Neal, Joel W and Leung, Ann N and Backhus, Leah M and Haiman, Christopher and Le Marchand, Loïc and Liang, Su-Ying and Wakelee, Heather A and Cheng, Iona and Han, Summer S},
  title = {Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae072}
}
Kostenlos starten →